Asthma Therapeutics Market, By Drug Class (Anti-inflammatory, Bronchodilators, and Combination Therapy), By Products (Inhalers and Nebulizers), By RoA, and Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025
108 Pages | Published Date : 20 / 08 / 17 | Report Code: AV105 | Report Format: PDF
The asthma therapeutics market is estimated to represent a global market of USD 19.8 billion by 2016 with growth rate of 1.9%.
Key drivers of the market include rising prevalence of asthma and other respiratory disorders. As per the World Health Organization (WHO), more than 235 million people suffer from asthma globally. Around 3,38,000 deaths were reported in 2015 and most deaths occur among older adults. Further, introduction of technologically advanced products and rising awareness levels about these disorders is anticipated to drive the market growth. Rising research in the field of biologics for asthma treatment is seen as most promising opportunity. Biologics targeting pro-inflammatory cytokines and other inflammatory mediators may be of therapeutic benefit. However, expiry of leading branded drugs such as Singulair (montelukast sodium), Symbicort (budesonide/formoterol fumarate), Advair (fluticasone propionate/salmeterol xinafoate), and Xolair (omalizumab) is anticipated to hamper the market growth.
Drug Class Takeaway
The global Asthma therapeutics market is segmented on the basis of drug class, product, route of administration and region. On the basis of drug class, the market is segmented into anti- inflammatory, bronchodilators and combination therapy. Combination therapy dominated the market share owing to its high adoption rates and utilization. Anti- inflammatory drugs are expected to witness market growth owing to R&D developments pertaining to biologics. Patent expiration of anti- inflammatory drugs during the forecast period will have impact on the revenue generation. Anti- inflammatory segment is expected to witness the fastest market growth.
On the basis of products offered by companies, the market is segmented into inhalers and nebulizers. Inhalers are most widely adopted owing to the patient compliance and ease of administration. They held the leading position in the market. Amongst inhalers, metered dose inhalers have been widely adopted due to their application in the long term therapy. Nebulizers are anticipated to grow at the highest CAGR during the forecast period.
Route of Administration Takeaway
On the basis of route of administration, the market is segmented into oral, inhaled and other routes. Inhaled route of administration accounted for the largest revenue in the year 2015. This is due to effective pharmacodynamics and pharmacokinetic actions upon administration of drug dose by this route. Oral route of administration is expected to emerge as the fastest growing market over the forecast period.
Geographically, the market is represented as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America dominated the overall asthma therapeutics market in terms of revenue share in 2014 at over 50.0%. The escalated incidence rate of asthma, increased awareness levels pertaining to treatment options, and the rising adoption of inhaled therapeutics are some of the major factors attributing the largest revenue share of this region. The European market is set to witness steady growth mainly due to the presence of a considerably developed pharmaceutical industry and the significant demand for asthma-related therapeutics. With the increasing geriatric population, susceptible to acquire respiratory conditions, such as asthma, will further support to the growth of regional market in the U.S.
Key Vendor Takeaway
Some of the key players in this industry include AstraZeneca Plc, Philips Healthcare, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Plc, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Roche Diagnostics, and Merck & Co., Inc. The market for asthma therapeutics is expected to experience steady growth primarily due to the branded drugs approaching their impending patent expiration dates and the intensive generic competition in the developing nations.
The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.
The years considered for the study are:
- Historical Year – 2014 & 2015
- Base Year – 2015
- Estimated Year – 2016
- Projected Year – 2025
- Traders, Distributors, And Suppliers
- Government and Regional Agencies and Research Organizations
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY DRUG CLASSS
- Combination Therapy
MARKET, BY PRODUCTS
MARKET, BY ROUTE
MARKET, BY REGION
- North America
- Asia Pacific
- Rest of the World
MARKET, BY COUNTRY
- Further Breakdown of The North America Market
- Further Breakdown of The Europe Market
- Rest of Europe
- Further Breakdown of The APAC Market
- Rest of APAC
- Further Breakdown of The Rest of the World Market
- Middle East and Africa
- Latin America
1. ASTHMA THERAPEUTICS MARKET OVERVIEW
1.1. Study Scope
1.2. Base Year
1.3. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. ASTHMA THERAPEUTICS KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. ASTHMA THERAPEUTICS INDUSTRY STUDY
4.1. Company Activity Analysis
4.2. Regulatory Framework Analysis
4.3. Pipeline Analysis
4.4. Value Chain Analysis
5. ASTHMA THERAPEUTICS MARKET LANDSCAPE
5.1. Market Share Analysis
6. ASTHMA THERAPEUTICS MARKET – BY DRUG CLASS:
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.4. Combination Therapy
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7. ASTHMA THERAPEUTICS MARKET – BY PRODUCTS:
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8. ASTHMA THERAPEUTICS MARKET – BY ROUTE:
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9. ASTHMA THERAPEUTICS MARKET– BY GEOGRAPHY
9.2. North America
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
184.108.40.206. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
220.127.116.11. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
18.104.22.168. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
22.214.171.124. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.3.5. Rest of Europe
126.96.36.199. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.4. Asia Pacific (APAC)
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
188.8.131.52. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
184.108.40.206. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.4.5. Rest of APAC
220.127.116.11. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.5. Rest of the World
9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.5.3. Latin America
18.104.22.168. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9.5.4. Middle East and Africa
22.214.171.124. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
10. KEY VENDOR ANALYSIS
10.1. AstraZeneca Plc
10.1.1. Company Overview
10.1.2. SWOT Analysis
10.1.3. Key Developments
10.2. Philips Healthcare
10.2.1. Company Overview
10.2.2. SWOT Analysis
10.2.3. Key Developments
10.3. Teva Pharmaceutical Industries Ltd.
10.3.1. Company Overview
10.3.2. SWOT Analysis
10.3.3. Key Developments
10.4. GlaxoSmithKline Plc
10.4.1. Company Overview
10.4.2. SWOT Analysis
10.4.3. Key Developments
10.5. Sanofi-Aventis SA
10.5.1. Company Overview
10.5.2. SWOT Analysis
10.5.3. Key Developments
10.6. CareFusion Corporation
10.6.1. Company Overview
10.6.2. SWOT Analysis
10.6.3. Key Developments
11. 360 DEGREE ANALYSTVIEW
12.1. Research Methodology
12.4. Contact Us
SCOPE AND OBJECTIVES :
The objective of this report is to describe the market trends and revenue forecasts for the market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.
The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analysing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the market by its major segments, which include the source, disease end user industry, and the major geographic regions.
KEY BENEFITS OF THE REPORT :
• Understanding of the strategies that are being adopted by the key players in this market to stay competitive
• Extensive analysis of the key players dominating the competitive landscape of this market
• In-depth analysis of the key factors are propelling the growth of the global market
• Detailed analysis of the geographic region that will witness the strongest growth
• Granular analysis of the current market scenario and the expected market grow
AnalystView’s research methodology is developed on a combination of specialist industry analyst knowledge and in-country research experience. We employ data interrogation methodologies to generate new and meaningful analyses and insights. The research study involves extensive usage of secondary sources, directories, and databases (such as Hoovers, Bloomberg, and Businessweek) to identify and collect information useful to understand technical, market-oriented, and commercial aspects of market. Market data and information are also collected and not limited to secondary sources like:
- Official Company’s Website, Financial and Annual Reporting
- Government Statistical Data
- Online Publishing Articles
- Industry Player’s Investor Presentations
- Economic News Articles
- National and International Trade Associations
- The Financial, Business and Mainstream Press
- Industry Study Groups and Other Semi-Official Sources
- Many Other Informative Channels Related to the Market Topics
Gathering data through secondary sources is only the first step. The ability to cross-refer market data through available secondary information often conflicting across multiple sources is a key aspect of the added value we provide
In order to verify and validate secondary market data, we engage with a variety of personnel in key players at all points through phone calls, emails and web based survey responses with key opinion leaders (KoL’s) operating in the respective markets. The engagement involves the CEO, vice presidents, top-level and middle-level managers of the company, directors of marketing, product managers, brand managers, customers of major industrial products, and many others. We also interview manufacturers, distributors, materials suppliers, retailers, service operators, study groups, industry associations, and third party observers from the trade and financial press. These obtained information helped us to understand several facets of the market with respect to manufacturers’ and buyers’ perspective. These data were carefully filtered, analyzed, compared and presented in an easy way to develop accurate research study. Furthermore, all collected data is subjected to undergo exhaustive review process at country level, regional level and global level.
Market forecast for the respective market is primarily based on the year on year (YOY) growth rate. Data projection and future performance of each segment analyzed based on the key aspects extracted from primary and secondary research results. Thus data projection states the assumption on how the market behaves under macroeconomic and microeconomic parameters. Our market forecasting represents strategic conclusion we have reached about the coming state of the market scenario.
Another integral part of our research study is that AnalystView’s market data is accompanied by clear written analysis. We include detail information on market segments in terms of market drivers, market restraints and market opportunities. These offer insights of different channel dynamics, brand preference, incidence/prevalence data, technology up gradation, consumption trend, and future market scenario. We also include supporting data with any relevant awareness campaign, new introduction, regulatory norms, government initiatives, and industry player’s expansion in specific product segments. From research perspective, this information explains and substantiates estimated data finding and forecast.
We strive to become one of the trusted partner of our client by offering value added services and concrete research data.
From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.
Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.
Data Accuracy and Reliability
We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.
We offer most competitive pricing policy across the research industry
Why Choose Us
We devise research report with quality data:
Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.
We work with businesses just like yours:
AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.